{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:57:32Z","timestamp":1781049452056,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["19 0040 Pj"],"award-info":[{"award-number":["19 0040 Pj"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2020\u201302446"],"award-info":[{"award-number":["2020\u201302446"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005689","name":"G\u00f6teborgs L\u00e4kares\u00e4llskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska University Hospital","doi-asserted-by":"publisher","award":["NHV-977897"],"award-info":[{"award-number":["NHV-977897"]}],"id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska University Hospital","doi-asserted-by":"publisher","award":["ALFGBG-965024"],"award-info":[{"award-number":["ALFGBG-965024"]}],"id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017018","name":"Goteborgs Universitet Wallenbergcentrum for molekylar och translationell medicin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejso.2024.108265","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T02:01:31Z","timestamp":1710208891000},"page":"108265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib\/II randomized double-blind placebo-controlled trial (NivoILP trial)"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3512-4535","authenticated-orcid":false,"given":"Carl-Jacob","family":"Holmberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1483-0625","authenticated-orcid":false,"given":"Lisanne P.","family":"Zijlker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9764-7526","authenticated-orcid":false,"given":"Dimitrios","family":"Katsarelias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Huibers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6173-0662","authenticated-orcid":false,"given":"Michel W.J.M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4872-7746","authenticated-orcid":false,"given":"Sophie J.M.","family":"Reijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6795-0497","authenticated-orcid":false,"given":"Johannes V.","family":"van Thienen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-6002","authenticated-orcid":false,"given":"Dirk J.","family":"Gr\u00fcnhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Martner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-6837","authenticated-orcid":false,"given":"Jonas A.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-5958","authenticated-orcid":false,"given":"Lars","family":"Ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winan J.","family":"van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-0355","authenticated-orcid":false,"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2024.108265_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1245\/ASO.2005.05.025","article-title":"Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy","volume":"12","author":"Pawlik","year":"2005","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108265_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1245\/s10434-014-4100-0","article-title":"In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy","volume":"22","author":"Read","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108265_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejso.2024.108265_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CMR.0000000000000719","article-title":"The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trials","volume":"31","author":"Olofsson Bagge","year":"2021","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2024.108265_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2022.03.041","article-title":"The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - a multicenter cohort study","volume":"169","author":"Holmberg","year":"2022","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2024.108265_bib6","article-title":"Efficacy of immune checkpoint inhibitors for in-transit melanoma","volume":"8","author":"Nan Tie","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2024.108265_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.10070","article-title":"Checkpoint inhibitor treatment in patients with isolated in-transit melanoma metastases","volume":"38","author":"Storey","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108265_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","article-title":"Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit","volume":"148","author":"Creech","year":"1958","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.108265_bib9","first-page":"157","article-title":"Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics","volume":"14","author":"Benckhuijsen","year":"1988","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108265_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1634\/theoncologist.2009-0325","article-title":"Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety","volume":"15","author":"Moreno-Ramirez","year":"2010","journal-title":"Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108265_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/02656736.2013.802374","article-title":"Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma","volume":"29","author":"Olofsson","year":"2013","journal-title":"Int J Hyperthermia"},{"issue":"7","key":"10.1016\/j.ejso.2024.108265_bib12","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1245\/s10434-017-5803-9","article-title":"Isolated limb perfusion for melanoma is safe and effective in elderly patients","volume":"24","author":"Madu","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108265_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/01.sla.0000146147.89667.ed","article-title":"One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases","volume":"240","author":"Gr\u00fcnhagen","year":"2004","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejso.2024.108265_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molmed.2008.02.002","article-title":"Immunogenicity of anthracyclines: moving towards more personalized medicine","volume":"14","author":"Apetoh","year":"2008","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.ejso.2024.108265_bib15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1158\/0008-5472.CAN-10-2788","article-title":"Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis","volume":"71","author":"Schiavoni","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2024.108265_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ejso.2024.108265_bib17","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2024.108265_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fonc.2018.00570","article-title":"Isolated limb perfusion with melphalan triggers immune activation in melanoma patients","volume":"8","author":"Johansson","year":"2018","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108265_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/02656736.2013.782428","article-title":"Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: a pilot study in patients with in-transit metastases of malignant melanoma","volume":"29","author":"Olofsson","year":"2013","journal-title":"Int J Hyperthermia"},{"issue":"24","key":"10.1016\/j.ejso.2024.108265_bib20","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1158\/0008-5472.CAN-15-1184","article-title":"Melphalan, antimelanoma immunity, and inflammation--letter","volume":"75","author":"Martner","year":"2015","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2024.108265_bib21","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.ejso.2021.04.038","article-title":"Anti-PD-1 checkpoint blockade improves the efficacy of a melphalan-based therapy in experimental melanoma","volume":"47","author":"Kiffin","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2024.108265_bib22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108265_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.108265_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2024.108265_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215485","article-title":"Role of isolated limb perfusion in the era of targeted therapies and immunotherapy in melanoma. A systematic review of the literature","volume":"13","author":"Sevilla-Ortega","year":"2021","journal-title":"Cancers"},{"issue":"25","key":"10.1016\/j.ejso.2024.108265_bib26","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1200\/JCO.2005.05.5152","article-title":"Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020","volume":"24","author":"Cornett","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108265_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/2326-6066.CIR-17-0356","article-title":"Robust antitumor responses result from local chemotherapy and CTLA-4 blockade","volume":"6","author":"Ariyan","year":"2018","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"10.1016\/j.ejso.2024.108265_bib28","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ejso.2022.01.027","article-title":"Isolated limb perfusion for locally advanced melanoma in the immunotherapy era","volume":"48","author":"Davies","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108265_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15020472","article-title":"Effects of the introduction of modern immunotherapy on the outcome of isolated limb perfusion for melanoma in-transit metastases","volume":"15","author":"Holmberg","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324003172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324003172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T20:47:08Z","timestamp":1737665228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324003172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0748798324003172"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108265","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of a single dose of nivolumab prior to isolated limb perfusion for patients with in-transit melanoma metastases: An interim analysis of a phase Ib\/II randomized double-blind placebo-controlled trial (NivoILP trial)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108265"}}